Elisa Schettino
4 Papers
Elisa Schettino is an academic researcher. The author has contributed to research in topics: Internal medicine & Chemistry. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study
Biagio Pinchera,Lorenzo Spirito,Antonio Riccardo Buonomo,Maria Foggia,Rosa Carrano,Fabrizio Salemi,Elisa Schettino,Fortuna Papa,Roberto La Rocca,Felice Crocetto,Luigi Napolitano,R. Villari,Ivan Gentile +12 more
TL;DR: Patients who received mTOR inhibitors, as part of their immunosuppressive therapy, compared to other regimens had a lower chance of developing a moderate or severe form of the disease (OR = 0.8, 95, CI: (0.21–0.92), P =0.041).
BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients
Evelina La Civita,Carla Zannella,S. Brusa,Paolo Romano,Elisa Schettino,Fabrizio Salemi,Rosa Carrano,Luca Gentile,Alessandra Punziano,Gianluca Lagnese,Giuseppe Spadaro,Gianluigi Franci,Massimiliano Galdiero,Daniela Terracciano,Giuseppe Portella,Stefania Loffredo +15 more
TL;DR: CVID and KTR patients had an efficient cell-mediated but not humoral response to SARS-CoV-2 vaccine, suggesting that the evaluation of T cell responses could be a more sensitive marker of immunization in these subjects.
Peri-transplant Treatment with Ceftaroline in Kidney Transplant Recipients at Risk of Donor-derived MRSA Infections: A Case Series
Biagio Pinchera,Rosa Carrano,Emilia Trucillo,Alessia D’Agostino,A. Sardanelli,S. Mercinelli,Fabrizio Salemi,Amerigo Piccione,Elisa Schettino,Paolo Romano,Gianluca Rompianesi,R. Troisi,Ivan Gentile +12 more
TL;DR: Real-life experience shows that Ceftaroline could represent a valid therapeutic option in the management of solid organ transplant patients with a risk of donor-derived MRSA infection, and this approach deserves further investigation in ad hoc studies or clinical trials due to the positive results.
Urinary tract infections in kidney transplant patients admitted to hospital: A real-life experience
Biagio Pinchera,Rosa Carrano,Elisa Schettino,Alessia D’Agostino,Emilia Trucillo,F. Cuccurullo,Fabrizio Salemi,Amerigo Piccione,Ivan Gentile +8 more
TL;DR: This study evaluates the epidemiology, clinical status, and treatment outcomes of urinary tract infections in kidney transplant patients, highlighting multidrug-resistant germs and immunosuppressive therapy as key factors in infection severity and management.